Clinical trial

Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes

NCT01662921

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention NPH Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Insulin LISPRO Normalized identity: insulin lisproView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Insulin glulisine Normalized identity: insulin glulisine, humanView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-04-01

PhasePHASE2

Conditions

Diabetes During Pregnancyunresolved

Interventions

NPHDRUG

Insulin LISPRODRUG · verified · RxNorm: insulin lispro

Insulin glulisineDRUG · verified · RxNorm: insulin glulisine, human

Sponsors & collaborators

Sansum Diabetes Research Institutelead sponsor

Sanoficollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01662921 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.